IMFINZI (Durvalumab) 500 mg Injection
IMFINZI Durvalumab 500 mg Injection is an advanced cancer immunotherapy medicine used for treating certain types of cancers. It contains Durvalumab, a programmed death-ligand 1 (PD-L1) inhibitor that helps the immune system recognize and destroy cancer cells more effectively. It is widely used in non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), and some biliary tract cancers, often as maintenance or combination therapy after chemotherapy or radiotherapy.
This medicine works as part of modern oncology immunotherapy, helping improve survival outcomes by strengthening the body’s natural anti-cancer immune response.
Contact Details to Place Order
💬 WhatsApp: +91 9730316395
📞 Phone: +91 9730316395
📧 Email: info@globmedindia.com
Composition and Content
- Active Ingredient: Durvalumab
- Strength: 500 mg per vial
- Dosage Form: Intravenous (IV) infusion
- Drug Class: Immune checkpoint inhibitor (PD-L1 monoclonal antibody)
How It Works
IMFINZI works by:
- Blocking PD-L1 proteins on cancer cells
- Reactivating immune T-cell response
- Helping immune system identify and attack tumors
- Slowing or stopping cancer progression
Uses and Treatments
IMFINZI (Durvalumab) Injection is used for:
- Non-Small Cell Lung Cancer (NSCLC)
- Extensive Stage Small Cell Lung Cancer (SCLC)
- Biliary Tract Cancer
- Bladder and urothelial cancers (selected cases)
- Maintenance therapy after chemoradiation
Dosage and How to Use
- Administered as intravenous infusion only in hospitals
- Given every 2–4 weeks depending on treatment protocol
- Dosage is determined by oncologist based on patient condition
- Must be used under strict medical supervision
Advantages of IMFINZI (Durvalumab)
- Enhances immune system response against cancer
- Improves survival in certain advanced cancers
- Used as maintenance therapy after chemotherapy/radiotherapy
- Targeted immunotherapy approach
- Helps delay disease progression
Storage Conditions
- Store at 2°C to 8°C (refrigerated)
- Do not freeze
- Keep in original packaging to protect from light
- Do not shake vial
- For clinical/hospital use only
Alternative Indian Brands / Options
Durvalumab is a patented immunotherapy, so direct Indian generics are not available. However, similar immune checkpoint inhibitor options include:
- Keytruda (Pembrolizumab) by Merck & Co.
- Opdivo (Nivolumab) by Bristol Myers Squibb
- Tecentriq (Atezolizumab) by Roche
- Oncology biosimilars and immunotherapy support drugs from Dr. Reddy’s Laboratories
All alternatives must be prescribed and managed strictly by an oncologist.
Buy IMFINZI Durvalumab 500 mg Injection Online in South Africa – Trusted Oncology Medicine Exporter
Looking to buy IMFINZI Durvalumab 500 mg Injection in South Africa? GlobMedIndia is a trusted international medicine exporter of oncology and immunotherapy drugs, offering safe, genuine, and high-quality cancer medicines with secure global delivery across South Africa.
We supply advanced immunotherapy medicines used in modern cancer treatment protocols with strict pharmaceutical standards and reliable export logistics.
Coverage includes major cities such as:
Johannesburg, Cape Town, Pretoria, Polokwane, Germiston, and Nelspruit.
Why Choose GlobMedIndia?
- Trusted exporter of oncology medicines
- Fast and secure international delivery
- 100% genuine pharmaceutical products
- Reliable global healthcare supply chain
- Expert support for medical procurement
- Buy Durvalumab 500 mg South Africa
- IMFINZI injection price Johannesburg Cape Town
- Lung cancer immunotherapy South Africa
- PD-L1 inhibitor medicine Africa
- Cancer immunotherapy injection South Africa
- Oncology medicine exporter South Africa
- GlobMedIndia cancer drugs
👉 Order Now for Fast, Safe & Secure Delivery Across South Africa & Neighboring Regions!
